Case Reports: Their Role in Treatment Approvals and Medicine
Exploring how individual case reports influence FDA approvals and medical advancements.
The Underestimated Role of Case Reports
Case reports, often considered the least prestigious form of medical literature, have played a pivotal role in advancing medical treatments. Despite being at the bottom of the evidence hierarchy, these reports account for approximately 12% of all publications indexed in PubMed. They provide unique insights into rare drug reactions and failed treatments, which larger clinical trials often overlook.
Mechanism and Context: From Observation to Approval
Case reports serve as a crucial source of information for rare drug reactions and failed treatments. A notable example is the FDA approval of esketamine for treatment-resistant depression, which was catalyzed by a 2022 case report. Similarly, a 1987 case report on hydroxychloroquine for porphyria eventually led to its FDA-approved indication 27 years later. These reports often capture unique patient responses that can spark further research and lead to significant medical advancements.
Policy and Research Implications
The impact of case reports extends beyond individual patient outcomes. They influence post-marketing surveillance and the FDA's adverse event reporting system, which received over 2 million reports in 2023 alone. This system acts as a vast collection of mini case reports, essential for detecting rare drug reactions that randomized controlled trials (RCTs) might miss. For researchers and clinicians, understanding the value of these reports can lead to more comprehensive medical practices and policies that better address patient needs.
Risks and Unknowns
While case reports can lead to significant medical advancements, they also pose challenges. The abundance of these reports can create noise, making it difficult to discern which observations are truly important. Additionally, the incentives for writing case reports are largely non-financial, driven by academic currency and journal economics, rather than direct contributions to medical knowledge. This can sometimes lead to an overemphasis on "interesting" cases rather than those with substantial clinical importance.
Looking Forward: The Future of Case Reports
As the medical community continues to recognize the value of case reports, their role in shaping medical practices is likely to grow. Researchers and policymakers may consider developing frameworks to better integrate these reports into the broader evidence hierarchy. By doing so, they can ensure that valuable insights from individual cases are not lost amidst the noise, ultimately leading to more effective and personalized medical treatments.
Get tomorrow's briefing in your inbox
Policy, research, and regulatory signal — delivered on our publish cadence.